New insights into the role of Vif in HIV-1 replication

AIDS Reviews

Volumn 6, Issue 1, 2004, Pages 34-39

  Schröfelbauer, Bärbel ^a   Yu, Qin ^a   Landau, Nathaniel R ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

HIV; HIV regulatory genes; Vif

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CD4 ANTIGEN; CYTIDINE DEAMINASE; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VIRUS PROTEIN;

GENETIC CODE; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MONOCYTE; NONHUMAN; OPEN READING FRAME; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION; REVIEW; T LYMPHOCYTE; VIRION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; CELL LINE; GENE PRODUCTS, VIF; HIV-1; HUMANS; NUCLEOSIDE DEAMINASES; PROTEINS; REPRESSOR PROTEINS; VIRUS REPLICATION;

EID: 2342666701     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Trono D. HIV accessory proteins: leading roles for the supporting cast. Cell 1995;82:189-92.
2. Emerman M, Malim M. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 1998;280:1880-4.
3. Sodroski J, Goh W, Rosen C, et al. Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science 1986;231:1549-53.
4. Gabuzda D, Lawrence K, Langhoff E, et al. Role of vif in replication of HIV type 1 in CD4+ T lymphocytes. J Virol 1992,66:6489-95.
5. Strebel K, Daugherty D, Clouse K, Cohen D, Folks T, Martin M. The HIV 'A' (sor) gene product is essential for virus infectivity. Nature 1987;328:728-30.
6. Von Schwedler U, Song J, Aiken C, Trono D. Vif is crucial for HIV type 1 proviral DNA synthesis in infected cells. J Virol 1993;67: 4945-55.
7. Simon J, Malim M. The HIV type 1 Vif protein modulates the post-penetration stability of viral nucleoprotein complexes. J Virol 1996;70:5297-305.
8. Cohen E, Subbramanian R, Gottlinger H. Role of auxiliary proteins in retroviral morphogenesis. Curr Top Microbiol Immunol 1996;214: 219-35.
9. Goncalves J, Korin Y, Zack J, Gabuzda D. Role of Vif in HIV type 1 reverse transcription. J Virol 1996;70:8701-9.
10. Gaddis N, Sheehy A, Malim M. Comprehensive investigation of the molecular defect in vif-deficient HIV type 1 virions. J Virol 2003;77: 5810-20.
11. Fouchier R, Simon J, Jaffe A, Malim M. HIV type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. J Virol 1996;70:8263-9.
12. Hoglund S, Ohagen A, Lawrence K, Gabuzda D. Role of vif during packing of the core of HIV-1. Virology 1994;201:349-55.
13. Simm M, Shahabuddin M, Chao W, Allan J, Volsky D. Aberrant Gag protein composition of a HIV type 1 vif mutant produced in primary lymphocytes. J Virol 1995;69:4582-6.
14. Simon J, Gaddis N, Fouchier R, Malim M. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat Med 1998;4: 1397-400.
15. Madani N, Kabat D. An endogenous inhibitor of HIV in human lymphocytes is overcome by the viral Vif protein. J Virol 1998;72: 10251-5.
16. Sheehy A, Gaddis N, Choi J, Malim M. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002;418:646-50.
17. Jarmuz A, Chester A, Bayliss J, et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 2002,79:285-96.
18. Harris R, Petersen-Mahrt S, Neuberger M. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol Cell 2002;10:1247-53.
19. Anant S, MacGinnitie A, Davidson N. Apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. J Biol Chem 1995;270:14762-7.
20. Lau P, Villanueva H, Kobayashi K, Nakamuta M, Chang B, Chan L. A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. J Biol Chem 2001;276:46445-52.
21. Yang Y, Sowden M, Smith H. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APO-BEC-1. J Bil Chem 2000;275:22663-9.
22. Muto T, Muramatsu M, Taniwaki M, Kinoshita K, Honjo T. Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. Genomics 2000;68:85-8.
23. Petersen-Mahrt S, Harris R, Neuberger M. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 2002;418:99-103.
24. Wedekind J, Dance G, Sowden M, Smith H. Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. Trends Genet 2003;19:207-16.
25. Imai K, Slupphaug G, Lee W, et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 2003;4:1023-8.
26. Ta V, Nagaoka H, Catalán N, et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat Immunol 2003;4:843-8.
27. Mariani R, Chen D, Schrofelbauer B, et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 2003;114:21-31.
28. Marin M, Rose K, Kozak SL, Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 2003;9:1398-403.
29. Stopak K, De Noronha C, Yonemoto W, Greene W. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell 2003; 12:591-601.
30. Sheehy A, Gaddis N, Malim M. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 2003;9:1404-7.
31. Harris R, Bishop K, Sheehy A, et al. DNA deamination mediates innate immunity to retroviral infection. Cell 2003;113:803-9.
32. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defense by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003,424:99-103.
33. Lecossier D, Bouchonnet F, Clavel F, Hance A. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 2003,300:1112.
34. Zhang H, Yang B, Pomerantz R, Zhang C, Arunachalam S, Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003;424:94-8.
35. Berkhout B, Grigoriev A, Bakker M, Lukashov V. Codon and amino acid usage in retroviral genomes is consistent with virus-specific nucleotide pressure. AIDS Res Hum Retroviruses 2002;18:133-41.
36. Berkhout B, Van Hemert F. The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins. Nucleic Acids Res 1994;22:1705-11.
37. Mehle A, Strack B, Ancuta P, Zhang C, McPike M, Gabuzda D. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J Biol Chem (in press).
38. Kao S, Khan M, Miyagi E, Plishka R, Buckler-White A, Strebel K. The HIV type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity. J Virol 2003; 77:11398-407.
39. Shindo K, Takaori-Kondo A, Kobayashi M, Abudu A, Fukunaga K, Uchiyama T. The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity. J Biol Chem 2003;278:44412-6.
40. Yu X, Yu Y, Liu B, et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003;302:1056-60.
41. Simon J, Southerling T, Peterson J, Meyer B, Malim M. Complementation of Vif-defective HIV type 1 by primate, but not nonprimate, lentivirus vif genes. J Virol 1995;69:4166-72.
42. Reddy T, Kraus G, Yamada O, Looney D, Suhasini M, Wong-Staal F. Comparative analyses of HIV-1 and HIV-2 Vif mutants. J Virol 1995;69:3549-53.
43. Liu B, Yu X, Luo K, Yu Y. Influence of primate lentiviral Vif and proteasome inhibitors on HIV type 1 virion packaging of APOBEC3G. J Virol 2004;78:2072-81.
44. Schrofelbauer B, Chen D, Landau N. A single amino acid of APOBEC3G controls its species-specific interaction with Vif. Proc Natl Acad Sci USA (in press).
45. Conticello S, Harris R, Neuberger M. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr Biol 2003;13:2009-13.
46. Kile B, Schulman B, Alexander W, Nicola N, Martin H, Hilton D. The SOCS box: a tale of destruction and degradation. Trends Biochem Sci 2002;27:235-41.